Technology
The NIH is launching a new website design focused on core themes to simplify public access to health and biomedical research information.
Finance
Mary-Claire King shares her experience and thoughts on the impact of her work amidst the suspense of the Nobel Prize anticipation.
Finance
Despite increased access to addiction medications for youth, retention remains alarmingly low, raising urgent concerns among healthcare professionals.
Finance
Enrollees in Medicare Advantage plans for 2027 need to prepare for higher out-of-pocket expenses and fewer benefits during the upcoming enrollment period.
Finance
A recent special issue of Science highlights the need for more research in women's health, particularly on menopause, pain mechanisms, and beyond.
Technology
Explore the vibrant pulse of China's biotech sector, offering firsthand insights into its rapid advancements and ongoing challenges.
Technology
Blue Shield of California aims to adopt Medicare-inspired payment models, enhancing care for six million members by 2027.
Technology
The Trump administration's latest Medicare drug pricing rule falls short, while Eli Lilly's combination therapy shows significant weight loss results.
Technology
Invivyd's Phase 3 study shows its monoclonal antibody, VYD2311, offers better tolerability than the Pfizer vaccine, suggesting a potential alternative for Covid-19 protection.
Technology
Despite a decline in effectiveness, Huntington's patient Lauren Holder remains optimistic about UniQure's gene therapy for slowing disease progression.
Sports
A significant surge in GLP-1 prescriptions for children highlights a growing response to childhood obesity and its medical implications.
Technology
Biotech leaders in Shanghai tout rapid drug development in China, positioning themselves as a competitive force against Western markets.
Sports
Eric Cantor seeks to reshape the pharmaceutical industry's image and policies to align with voter concerns, revisiting past strategies aimed at broader public appeal.
Technology
Research highlights the long-term respiratory risks posed by toxic metals from the 2023 Maui wildfires, persisting even after the flames have subsided.
Technology
Merck's recent decision to discontinue Recarbrio raises questions about the pharmaceutical industry's commitment to tackling antibiotic resistance.